Jerome Ritz
Impact in
- Hematology top 0.01%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Immunology top 0.01%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Hematology 332
- Hematopoietic Stem Cell Transplantation 258
- Acute Myeloid Leukemia Research 66
- Immunology 372
- Immune Cell Function and Interaction 225
- T-cell and B-cell Immunology 192
- Immunotherapy and Immune Responses 90
- Co-authors
- Robert J. Soiffer (209 shared papers)Edwin Pascal Alyea (139 shared papers)Joseph H. Antin (150 shared papers)Stuart F. Schlossman (32 shared papers)Corey S. Cutler (126 shared papers)Haesook T. Kim (109 shared papers)Vincent T. Ho (114 shared papers)MJ Robertson (4 shared papers)
- Journals
- Blood (225 papers)Transplantation and Cellular Therapy (60 papers)The Journal of Immunology (25 papers)Blood Advances (24 papers)Journal of Clinical Investigation (21 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Jerome Ritz
677 papers receiving 48.9k citations
Jerome Ritz's Hit Papers
Peers
Comparison fields: 5 of 177
- Hematology 16.7k
- Immunology 24.2k
- Genetics 6.4k
- Oncology 14.5k
- Transplantation 913
Countries citing papers authored by Jerome Ritz
This map shows the geographic impact of Jerome Ritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Ritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Ritz more than expected).
Fields of papers citing papers by Jerome Ritz
This network shows the impact of papers produced by Jerome Ritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Ritz. The network helps show where Jerome Ritz may publish in the future.
Co-authors
The 25 scholars most cited alongside Jerome Ritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 708 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An immunogenic personal neoantigen vaccine for patients with melanoma Hit paper breakdown → | 2017 | 2347 |
| 2 | Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial Hit paper breakdown → | 2018 | 1172 |
| 3 | Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease Hit paper breakdown → | 2011 | 934 |
| 4 | Biology and clinical relevance of human natural killer cells Hit paper breakdown → | 1990 | 815 |
| 5 | Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease Hit paper breakdown → | 1989 | 696 |
| 6 | Activation of a novel human transforming gene, ret, by DNA rearrangement Hit paper breakdown → | 1985 | 684 |
| 7 | A monoclonal antibody to human acute lymphoblastic leukaemia antigen Hit paper breakdown → | 1980 | 655 |
| 8 | 2006 | 631 | |
| 9 | CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation Hit paper breakdown → | 2017 | 619 |
| 10 | Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma Hit paper breakdown → | 1991 | 597 |
| 11 | Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. Hit paper breakdown → | 1979 | 553 |
| 12 | The elusive nature and function of mesenchymal stem cells Hit paper breakdown → | 2011 | 544 |
| 13 | Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. | 1997 | 512 |
| 14 | Ipilimumab for Patients with Relapse after Allogeneic Transplantation Hit paper breakdown → | 2016 | 510 |
| 15 | Expression of myeloid differentiation antigens on normal and malignant myeloid cells. Hit paper breakdown → | 1981 | 498 |
| 16 | 1991 | 432 | |
| 17 | 2013 | 410 | |
| 18 | Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease Hit paper breakdown → | 2020 | 407 |
| 19 | 2005 | 400 | |
| 20 | Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma Hit paper breakdown → | 2017 | 395 |
About Jerome Ritz
Jerome Ritz is a scholar working on Hematology, Immunology, Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 708 papers that have together received 51.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (258 papers), Immune Cell Function and Interaction (225 papers), T-cell and B-cell Immunology (192 papers), Immunotherapy and Immune Responses (90 papers), CAR-T cell therapy research (83 papers), Chronic Lymphocytic Leukemia Research (67 papers), Acute Myeloid Leukemia Research (66 papers) and Monoclonal and Polyclonal Antibodies Research (64 papers). The work is most often cited by research in Hematology (16.7k citations), Immunology (24.2k citations), Genetics (6.4k citations), Oncology (14.5k citations) and Transplantation (913 citations). Jerome Ritz has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Robert J. Soiffer, Edwin Pascal Alyea, Joseph H. Antin, Stuart F. Schlossman, Corey S. Cutler, Haesook T. Kim, Vincent T. Ho, MJ Robertson, Donna S Neuberg and John Koreth. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, The Journal of Immunology, Blood Advances and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.